Nat. Prod, 1987; Pettit et al, J. This Downing structure was fitted to the amino acid sequences for porcine brain a- and b-tubulin, which, for the beta subunit, is largely bII. In support of this statement, the Jordan et al. Cell. Biol, 91: 479-487, 1981), and by J. MK-0524A has been approved in more than 60 countries outside the United States for the treatment of dyslipidemia, particularly in patients with combined mixed dyslipidemia (characterized by elevated levels of LDL-C and triglycerides and low HDL-C) and in patients with primary hypercholesterolemia (heterozygous familial and non-familial) and is marketed as Tredaptive (or as Cordaptive in certain countries). MK-8616 (Bridion) (U. For a description of the research and development process, see Item 1. RICHARD R. DELUCA, JR. No. 10/867,517 (filed on Jun. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Similarly, for the Vinca alkaloids, it is unclear why they are frequently most effective against haematological cancers, but often ineffective against many solid tumors. July 2006 — President, U. J. D. Thompson et al. In one preferred embodiment, the magnetic anti-mitotic compound of this invention is not removed by these membrane pumps. Thus, natural products and organic compounds that interfere with microtubule formation have been used successfully as chemotherapeutic agents in the treatment of various human cancers. The basis for this statement was an article by P. The Company faces significant litigation related to Vioxx. Prior to March 2010, Ms. Heller was President, Johnson & Johnson’s Baby Global Business Unit from 2007 to 2010 and President for Global Baby, Kids and Wound Care from 2005 to 2007. Expert! The entire disclosure of each of these United States patents is hereby incorporated by reference into this specification. MK-7009, vaniprevir, is an investigational, oral twice daily protease inhibitor for the treatment of chronic hepatitis C virus. All aspects of the Company’s business, including research and development, manufacturing, marketing, pricing, sales, litigation and intellectual property rights, are subject to extensive legislation and regulation. In one embodiment of this invention, prior art beta-tubulin targeting agents are modified by making them water-soluble and/or magnetic in accordance with the process of this invention. S. Food and Drug Administration (the “FDA”) and the European Commission (the “EC”). Whitehouse Station, N. Soc. Trans, 8: 1347-1354, 1980), by S. J& J also received a one-time payment from Merck of $500 million in April 2011. These sequences would be readily available for interactions with other proteins in a projecting C-terminus. The biding site for paclitaxel is in the beta-subunit, and its location, which is on the inside surface of the microtubule, is known with precision.. In 1998, Merck and Astra restructured the joint venture whereby Merck acquired Astra’s interest in the joint venture, renamed KBI Inc. To suppress microtubule dynamics for a significant time, the drugs must bind to and act directly on the microtubule. A positive skin control and negative controls (minus antibody) were run with each batch of tumors.. Any significant breakdown, intrusion, interruption or corruption of these systems or data breaches could have a material adverse effect on our business. HTI-286, a synthetic analogue of the tripeptide hemiasterin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo, Cancer Res, 63: 1838-1845, 2003). Pill imprint L368 has been identified as naproxen 220 mg. View images and comprehensive information for this drug. S. pharmaceutical business is conducted through divisional headquarters located in Upper Gwynedd and Whitehouse Station. Microtubules show two kinds of non-equilibrium dynamics, both with purified microtubule systems in vitro and in cells. As is also discussed elsewhere in this, and in one preferred embodiment, the anti-mitotic compounds and/or compositions of this invention are adapted to bind one or more of the tubulin isotypes expressed by such mutants. Slides were counter-stained with methyl green. This conformational complexity has many implications (Pal et al, 2001). The Company’s operations are principally managed on a products basis and are comprised of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment, which is the Pharmaceutical segment. The law also requires pharmaceutical manufacturers to pay a 50% discount to Medicare Part D beneficiaries when they are in the Medicare Part D coverage gap (i.e, the so-called “donut hole”). However, the Company closely reviews its methods of operations and adopts strategies responsive to changing economic and political conditions. Clin. Oncol, 20: 1115-1127, 2002), and by B. The degree to which vinblastine binds to tubulin depends upon whether the tubulin is exposed or buried. In one preferred embodiment of this invention, the magnetic anti-mitotic compound of this invention binds to, and inactivates, a tubulin isotype that causes, or tends to cause, drug-resistance. At page 256 of the Jordan et al. During 2011, the FDA approved an expanded age indication for Zostavax, a vaccine to help prevent shingles (herpes zoster), to include adults ages 50 to 59.
Anti diabetes drug 44334
In addition, unfavorable outcomes resulting from the shareholder litigation concerning the ENHANCE clinical trial results could have a material adverse effect on the Company’s business, cash flow, results of operations, financial position and prospects. Med. Chem. Anti-Cancer Agents, 2: 123-148, 2002), by F. Eleven percent of compounds had a MWT of over 500.. As support for this statement, the 2004 Jordan et al. Oncol, 30: 9-25, 2003), and by J. First, for the timely and correct attachment of chromosomes at their kinetochoares to the spindle during prometaphase after nuclear-envelope breakdown.. The smaller the CI value, the greater the synergistic effect. These amounts do not consider potential recoveries from other parties. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Item 8. In accordance with one embodiment of this invention, there is provided a water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000×10−6 cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200×10−6 cgs. It is clear that microtubule dynamics in cells are regulated by a host of mechanisms: cells can alter their expression levels of 13 tubulin isotypes; they can alter their levels of tubulin post-translational modifications; they can express mutated tubulin; and they can alter the expression and phosphorylation levels of microtubule-regulatory proteins.. The Company faces intense competition from competitors’ products which, in addition to other factors, could in certain circumstances lead to non-cash impairment charges. Chem, 1993; Rao et al, Tetrahedron Lett, 1993), the Combretastatins (Lin et al, Biochemistry, 1989; Pettit et al, J. ANG tubulin monomer is made up of a 205 amino acid N-terminal GTP/GDP binding domain with a Rossman fold topology typical for nucleotide-binding proteins, a 180 amino acid intermediate domain comprised of a mixed β sheet and five helices which contain the taxol binding site, and a predominantly helical C-terminal domain implicated in binding of microtubule-associated protein (MAP) and motor proteins.. S. Pat. No. 5,888,818, Among certain weed species, some biotypes have evolved resistance to dinitroaniline herbicides. In April 2010, AstraZeneca exercised the Asset Option. Reference may be had, e.g, to an article by E. The Company does not regard these risks as a deterrent to further expansion of its operations abroad. In addition to α- and β-tubulin, many microtubules in cells require the related γ-tubulin for nucleation. The biology of the combretastatins as tumour vascular targeting agents, Int. This application is a continuation-in-part of applicants' U. S. Pat. No. 6,541,509 may be adapted to use the magnetic compound of this invention instead of discodermolide. Changes in microtubule dynamics can lead to altered sensitivity to microtubule-targeted drugs. Microtubule dynamics are crucial to mitosis.. As the Animal Health segment of the Company’s business becomes more significant, the impact of any such events on future results of operations would also become more significant. Three examples of species in which dinitroaniline resistant (R) biotypes have emerged are goosegrass, Eleusine indica (Mudge et al, 1984, Weed Sci, 32, 591-594); green foxtail, Setaria viridis (Morrison et al, 1989, Weed Technol, 3, 554-551); and Amaranthus palmeri (Gossett et al, 1992, Weed Technology, 6:587-591). The Company’s operations may be affected by technological advances of competitors, industry consolidation, patents granted to competitors, competitive combination products, new products of competitors, the generic availability of competitors’ branded products, new information from clinical trials of marketed products or post-marketing surveillance and generic competition as the Company’s products mature. The process of vascular shutdown can be observed in rats through windowed chambers that are implanted subcutaneously. Nucleotide-dependent movements of the kinesis motor domain predicted by simulated annealing, Biophys. The Company currently has two candidates under regulatory review in the United States and internationally. BII as a chemotherapeutic target. Table 1 is presented regarding Antimitotic drugs, their diverse binding sites on tubulin and their stages of clinical development. The discovery of the synergistm of paclitaxel with discodermolide is particularly interesting, as both drugs bind to the same or overlapping sites on tubulin or microtubules. These include the volume, surface area, net charge, and dipole moments. Using the Molecular Simulation International (MSI) Homology Software Module, we have constructed three-dimensional models of the abI, abII, abIII, abIV, abV, abVI and abVII dimers. The exercise price for the Shares Option will be primarily based on the net present value of projected future pretax revenue to be received by Merck from Nexium and Prilosec as determined at the time of exercise, subject to certain true-up mechanisms. The Company currently has two candidates under review with the FDA: MK-8669, ridaforolimus, for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy and MK-0653C, Zetia combined with atorvastatin for the treatment of primary or mixed hyperlipidemia. Hamel, Natural products which interact with tubulin in the Vinca domain: maytarsine, rhizoxin, phomopsin A. Reference may be had, e.g, to articles by R. The Company anticipates filing a BLA for V419 with the FDA in 2014. Thus, as is disclosed at page 260 of the 2004 Jordan et al. Further, it should be kept in mind, that the charge on a tubulin dimmer will be neutralized in solution due to the presence of counter-ions which almost completely screen the net charge. The C terminal end of the beta-tubulins starting from amino acid 430 is regarded as highly variable between the various classes. Our structural experiments on purified abII, abIII and abIV tubulin dimers have produced strong evidence that their conformations differ. For example, the outbreak of disease carried by animals, such as Bovine Spongiform Encephalopathy or mad cow disease, could lead to their widespread death and precautionary destruction as well as the reduced consumption and demand for animals, which could adversely impact the Company’s results of operations. Differences in rates of endothelial-cell proliferation, in post-translational modifications of tubulin, and in interactions between actin and microtubules might also contribute to the specificity of vascular targeting agents. Antitumor 2,3-dihydro-2-(aryl)-4(1H) quinazolinone derivatives: interactions with tubulin, Biochem. The paper in question is entitled Homology Modeling of Tubulin Isotypes and its Consequences for the Biophysical Properties of Tubulin and Microtubules. The aforementioned neoplasias may also be treated by the process of the instant invention. Competitive pressures have intensified as pressures in the industry have grown. 2013年9月30日 - Diabetes mellitus • DM is characterized by elevated blood sugar levels due to absolute or relative lack of insulin. • Type 1 diabetes - β- Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing ophthalmic products. Claim 1 of this patent describes: A method of treating neoplasia in a subject in need of treatment, comprising administering to the subject an amount of paclitaxel effective to treat the neoplasia, in combination with an amount of discodermolide effective to treat the neoplasia, wherein a synergistic antineoplastic effect results. Jordan paper, wherein it is disclosed that: The polymerization if microtubules occurs by a nucleation-elongation mechanism in which the relatively slow formation of a short microtubule ‘nucleus' is followed by rapid elongation of the microtubule at its ends by the reversible, non-covalent addition of tubulin dimers.. Harnel et al. These authors concluded from their work that the two types of microtubule lattices (A and B) correspond to the local energy minima. The Company and its subsidiaries own their principal facilities and manufacturing plants under titles that they consider to be satisfactory. The Company plans to file five major products for approval between 2012 and 2013, including: suvorexant (insomnia), Bridion (reversal of neuromuscular blockade), V503 (cervical cancer vaccine), odanacatib (osteoporosis) and Tredaptive (atherosclerosis). As is disclosed in U. In another embodiment, the magnetic anti-mitotic drugs of this invention bind to the polymerized tubulin in the microtubules. New tubulins in protozoal parasites, Curr. 44334 11/20/2012. 399940 11/5/2013. 100000 11/5/2013. 133203 11/14/2006. 146416 3/18/2014. 80000 6/18/2013. 80000 11/25/2014. 400000 11/15/2011. 374000.. anti diabetes drugs Manufacturers & anti diabetes drugs Suppliers Directory - choose anti diabetes drugs from 1537 anti diabetes drugs Super Suppliers of Chin Accurate modeling of the intramolecular electrostatic energy of proteins, J. A chart listing the U. Over-the-Counter Products: Claritin non-drowsy antihistamines; MiraLAX treatment for occasional constipation; Coricidin HBP decongestant-free cold/flu medicine for people with high blood pressure; Afrin nasal decongestant spray; and Zegerid OTC treatment for frequent heartburn. The Company’s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, and generic drug and consumer health care manufacturers. Preferably, the β-tubulin modifying agents are substituted benzene compounds, pentafluorobenzenesulfonamides, arylsulfonanilide phosphates, and derivatives, analogs, and substituted compounds thereof (see, e.g, U. Second, for the complex movements of the chromosomes that bring them to their properly aligned positons at the metaphase plate.. The Company may not be able to realize the expected benefits of its investments in emerging markets. Since inception of the Merger Restructuring Program through December 31, 2011, Merck has eliminated approximately 18,430 positions comprised of employee separations, as well as the elimination of contractors and more than 2,500 positions that were vacant at the time of the Merger. The Verdier-Pinard et al. In February 2012, Merck announced the top-line results of the TRA-2P study. Aggregate market value of Common Stock ($0.50 par value) held by non-affiliates on June 30, 2011 based on closing price on June 30, 2011: $108,759,000,000. Applicants believe that the magnetic anti-mitotic compound of their invention is as effective as is paclitaxel in.. J. Lowe et al. Inhibition of cathepsin K is a novel approach to the treatment of osteoporosis. In addition, beginning July 1, 2011, all profits derived from Merck’s exclusive distribution of the two products in the Retained Territories are being equally divided between Merck and J& J. In addition, in February 2012, the FDA approved Cosopt PF, Merck’s preservative-free formulation of Cosopt ophthalmic solution, indicated for the reduction of elevated intraocular pressure in appropriate patients with open-angle glaucoma or ocular hypertension. Merck has expanded its operations in countries located in Latin America, the Middle East, Africa, Eastern Europe and Asia Pacific. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells, Proc. How to. Quais as contra-indicações? A terapia de ondas acústicas é um método inovador e altamente eficaz no combate à celulite e contra a perda de elasticidade da pele. S. Pat. No. 6,541,509, In the method of the present invention, an amount of paclitaxel or discodermolide that is ‘effective to treat the neoplasia' is an amount that is effective to ameliorate or minimize the clinical impairment or symptoms of the neoplasia, in either a single or multiple dose. Published United States patent application 2002/0106705, the entire disclosure of which is hereby incorporated by reference into this specification, describes a method for detecting a modified beta-tubulin isotype. The Company will continue to hire employees in strategic growth areas of the business as necessary. In the Marti-Renom paper, it is stated that the MODELLER database is disclosed at guitar. F. Luduena et al. As basis for this statement, articles were cited by M. Additionally, the members of the same class seem to be very conserved between the various species. Cell Sci. 106: 209-218, 1993), by W. Keskin et al, Relating molecular flexibility to function: a case study of tubulin, Biphysical Journal 83:663-680, 2002. Bridion is currently approved and has been launched in many countries outside of the United States. J. H. Lowe et al. Drug & Dosing Information. Pharmaceutic management or physical therapy for older adult knee-pain patients yielded significantly greater short-term pain reduction The molecular target for dinitroaniline herbicides is believed to be tubulin proteins which are the principle constituents of microtubules (Strachan and Hess, 1983, Pestic Biochem Physiology, 20, 141-150; Morejohn et al, 1987, Planta, 172, 252-264). Many countries have announced austerity measures, which include the implementation of pricing actions to reduce prices of generic and patented drugs. Cancer Res, 6: 1978-1987, 2000), and another article by Martello et al. These increases were partially offset by lower sales of Cozaar (losartan potassium) and Hyzaar (losartan potassium and hydrochlorothiazide), treatments for hypertension, which lost patent protection in the United States in April 2010 and in a number of major European markets in March 2010, as well as by lower sales of Caelyx, Subutex and Suboxone as the Company no longer has marketing rights to these products. Number of shares of Common Stock ($0.50 par value) outstanding as of January 31, 2012: 3,044,008,396. Juvisync is the first treatment option for health care providers to help patients who need the blood sugar-lowering benefits of a DPP-4 inhibitor and the cholesterol-lowering benefits of simvastatin, with the convenience of a single tablet once daily. The patent rights that protect its products are of varying strengths and durations. The principal market for trading of the Company’s Common Stock is the New York Stock Exchange (“NYSE”) under the symbol MRK. D. Sept et al, The physical basis of microtubule structure and stability, Protein Science, 12:2257-2261, 2003. According to the Jordan et al. Similar homology modeling approaches have been used to predict the structure of one protein from that of a closely related protein; such models have also been extensively used to design useful drugs.
In the first part of this specification, applicants will discuss the preparation of a database of tubulin isotopes. The Company anticipates filing a new drug application for MK-7009 in Japan in 2014. The Company recognized the $443 million of deferred income in 2010 as a component of Other (income) expense, net. Taxol displays a broad spectrum of tumorcidal activity including against breast, ovary and lung cancer (McGuire et al, 1996, N. Teva Pharmaceutical Industries Ltd. A further problem underlying the present invention was to provide the means to extend possible screening programs for cytostatic agents to other isotypes of human beta-tubulins. The Company is not currently able to estimate any additional amounts that it may be required to pay in connection with the Vioxx Lawsuits. A ‘synergistic antineoplastic effect' refers to a greater-than-additive antineoplastic effect which is produced by a combination of two drugs, and which exceeds that which would otherwise result from individual administration of either drug alone. Prior to the Merger, Schering-Plough commenced a Productivity Transformation Program, which was designed to reduce and avoid costs and increase productivity. Women’s Health and Endocrine: Fosamax (alendronate sodium) for the treatment and prevention of osteoporosis; NuvaRing (etonogestrel/ethinyl estradiol vaginal ring), a vaginal contraceptive ring; Follistim AQ (follitropin beta injection), a biological fertility treatment; Implanon (etonogestrel implant), a single-rod subdermal contraceptive implant; and Cerazette (desogestrel), a progestin only oral contraceptive. The ‘rule of 5' states that: poor absorption of permeation is more likely where: A. Additionally, the formulations may be presented with disintegrators, such as corn starch, potato starch, or sodium carboxymethyl-cellulose. Furthermore, these European austerity measures could negatively affect the Company’s revenue performance in 2012 more than the Company anticipates. Changes to the health care system enacted as part of health care reform in the United States, as well as increased purchasing power of entities that negotiate on behalf of Medicare, Medicaid, and private sector beneficiaries, could result in further pricing pressures. Outside the United States, through subsidiaries, the Company owns or has an interest in manufacturing plants or other properties in Australia, Canada, Japan, Singapore, South Africa, and other countries in Western Europe, Central and South America, and Asia. What are the features of. If the conditions in Europe worsen and one or more countries in the euro zone exits the euro zone and reintroduces its legacy currency, the resulting economic and currency impacts in the affected markets and globally could have a material adverse effect on the Company’s results. See, e.g, an article by R. Prior to Merck’s acquisition of the rights to vernakalant i.v. Microtubule polymer levels and dynamics are regulated by a host of factors, including expression of regulatory proteins, post-translational modifications of tubulin and expression of different tubulin isotypes. Also during this stage, the proposed manufacturing facility undergoes a pre-approval inspection during which production of the vaccine as it is in progress is examined in detail. Biol. Chem. 270:31269-31275; and Giannakakou et al, 1997, J. Such agents (including non-chemical stresses) are hereinafter referred to as ‘anti-tubulin agents' as they share a similar type of mode of action.
Changes in laws and regulations could adversely affect the Company’s business. S. Pat. No. 5,888,818, It has not been previously shown which specific gene is modified in Eleusine indica or Setaria viridis to confer the dinitroaniline resistance trait. In the case of products that contribute significantly to the Company’s sales, the loss of patent protection can have a material adverse effect on the Company’s business, cash flow, results of operations, financial position and prospects. The Company is subject to evolving and complex tax laws, which may result in additional liabilities that may affect results of operations. In one embodiment of this invention, the anti-mitotic compound of this invention binds to, and inactivates, one or more of these other forms of tubulin. Synthetic paclitaxel, for example, can be obtained from Bristol-Myers Squibb Company, Oncology Division (Princeton, N. Any such proposal that is enacted into law could worsen this substantial negative effect on the Company’s sales and, potentially, its business, cash flow, results of operations, financial position and prospects. Rituximab: a review of its use in non-Hodgkins lymphoma and chronic leukemia, Drugs, 63: 803-843, 2003), by A. The anti-mitotic drugs may also interfere with oscillations. Sullivan K. F, 1988, Ann. FIG. 5 shows the energy levels of different orientational positons of the C-termini in a toy model and suggests that there is relatively little energetic difference between projecting straight outward from the rest of the tublin and lying on the surface of tubulin in certain energy minima.. Referring again to the Tuszynksi paper, it is disclosed that:.. The cited reference 48 is an article by Hall et al, The fractional inhibitory concentration (FIC) as a measure of synergy, J. All of these suits are referred to as the “Vioxx Foreign Lawsuits”.) Merck has also been sued by a number of states, one county and a private citizen as a qui tam lawsuit with respect to the marketing of Vioxx. As is also disclosed in the Tuszynski paper, As an initial step the Swiss-Prot database Release 40.2 of 8 Nov. Under civil settlement agreements signed with the United States and individually with 44 states and the District of Columbia, Merck will pay approximately two-thirds of the reserved charge to resolve civil allegations related to Vioxx. In one embodiment, the anneal program is used to heat up the proteins from a temperature of from about 1 to about 299 degrees Kelvin to a temperature within the range of from about 300 to about 500 degrees Kelvin linearly over a period of from about 100 to about 100,000 picoseconds, preferably, over a period of at least about 200 picoseconds. A method of monitoring the amount of a tubulin modified at a cysteine residue at amino acid position 239 in a patient treated with a sulfhydryl or a disulfide tubulin modifying agent, the method comprising the steps of: (a) providing a sample from the patient treated with the tubulin modifying agent; (b) contacting the sample with an antibody that specifically binds to the tubulin modified at a cysteine residue at amino acid position 239; and (c) determining the amount of the tubulin modified at a cysteine residue at amino acid position 239 in the patient sample by detecting the antibody and comparing the amount of antibody detected in the patient sample to a standard curve, thereby monitoring the amount of the tubulin modified at a cysteine residue at amino acid position 239 in the patient. The Company may also be required to increase its reliance on third-party agents within less developed markets. The Company anticipates filing an NDA for MK-3641 with the FDA in 2013. In December 2007, Schering-Plough and Centocor revised their distribution agreement regarding the development, commercialization and distribution of both Remicade and Simponi, extending the Company’s rights to exclusively market Remicade to match the duration of the Company’s exclusive marketing rights for Simponi. The constituents of microtubules are heterodimers consisting of one α-tubulin molecule and one β-tubulin molecule. At least one reason that cancer cells are relatively sensitive to these drugs compared to normal cells is that cancer cells divide more frequently than normal cells and therefore frequently pass though a stage of vulnerability to mitotic poisons. Dolostatins 10 and 15 and halichondrin B, Pharmacol. If successful, the Company submits regulatory filings with the appropriate regulatory agencies. Limited Time Offer, Buy It Now! B. Hastie (Interactions of colchicines with tubulin, Pharmacol. The Company believes that it has meritorious defenses to the Vioxx Product Liability lawsuits, Vioxx Securities Lawsuits and Vioxx Foreign Lawsuits (collectively, the “Vioxx Lawsuits”) and will vigorously defend against them. Before a new drug or vaccine may be marketed in the United States, recorded data on preclinical and clinical experience are included in the NDA for a drug or the Biologics License Application (“BLA”) for a vaccine or biologic submitted to the FDA for the required approval. The cooling process is maintained at a low enough rate so that the molecule can move between minima and find a lower energy final conformation. Completion of an annual cycle of care for patients with diabetes mellitus Revenue was also negatively affected by lower sales of Vytorin, a cholesterol modifying medicine, Temodar, a treatment for certain types of brain tumors, ProQuad, a pediatric combination vaccine to help protect against measles, mumps, rubella and varicella, and Varivax, a vaccine to help prevent chickenpox (varicella). S. market exclusivity for Singulair, which is the Company’s largest selling product with U. The LogP is over 500.. If previously unknown side effects are discovered or if there is an increase in negative publicity regarding known side effects of any of the Company’s products, it could significantly reduce demand for the product or require the Company to take actions that could negatively affect sales, including removing the product from the market, restricting its distribution or applying for labeling changes. Tredaptive should be used in patients in combination with statins when the cholesterol lowering effects of statin monotherapy is inadequate. S. V. Ambdukar et al. High LDL-C, low HDL-C and elevated triglycerides are risk factors associated with heart attacks and strokes. Thus, e.g, claim 17 of this patent discloses: 17. Thus, as is apparent from this teaching, the magnetic, anti-mitotic drugs disclosed in this specification may be used not only to treat cancer but also as.. Do Statins Cause Diabetes? The Numbers Behind The Anti-Vaccine Movement. View all. Mental Health. Add to compare items Choose a second drug to compare.. Johnson et al, 1996, J. As will be apparent, in applicants' invention the discodermolide is replaced by the magnetic anti-mitotic compound described in this specification. Since the late 1990s, the combestatins and N-acetylcolchicinol-O-phosphate, compounds that resemble colchicines and bind to the colchicines domain on tubulin, have undergone extensive development as antivascular agents.. SP was found to inhibit the binding of vinc alkaloids (but not colchicin) to tubulin., indicating that the binding site for this potent tubulin depolymerizing agent may also serve as a binding region for vinc alkaloids. The law also requires pharmaceutical manufacturers to pay a 50% discount to Medicare Part D beneficiaries when they are in the Medicare Part D coverage gap (i.e, the so-called “donut hole”). In one embodiment of the process used in the Tuszynksi paper, the.. In addition, revenue in 2011 benefited from higher sales of the Company’s animal health products and from the launch of Victrelis (boceprevir), a treatment for chronic hepatitis C. As is also disclosed in the Tuszynski paper, FIG. Dinitroaniline herbicides are widely used to control weeds in arable crops, primarily for grass control in dicotyledonous crops such as cotton and soya. Failure of these third parties to meet their contractual, regulatory and other obligations to the Company or the development of factors that materially disrupt the relationships between the Company and these third parties could have a material adverse effect on the Company’s business. Downing and co-workers at a resolution of 3.7.
Both polypeptides are highly flexible globular proteins (approximately 445 amino acids), each with a predicted 25%. Malignant neoplasms are distinguished from benign in that the former show a greater degree of anaplasia, or loss of differentiation and orientation of cells, and have the properties of invasion and metastasis. S. Pat. No. 5,453,937 (method and system for protein modeling); U. MK-8175A, NOMAC/E2, which is being marketed as Zoely in the EU, is an oral contraceptive for use by women to prevent pregnancy. The revenue increase over 2009 was driven largely by incremental sales resulting from the inclusion of a full year of results in 2010 for legacy Schering-Plough products such as Remicade, Nasonex, Temodar, PegIntron and Clarinex, as well as by the inclusion of a full year of results for Merck/Schering-Plough Partnership (“MSP Partnership”) products Zetia and Vytorin. Box 1) how one may measure microtubule dynamic instability. In February 2012, the FDA approved Janumet XR (sitagliptin and metformin HCI extended-release), a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of Januvia, with extended-release metformin in a once-daily formulation; Cosopt PF (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2.0%/0.5%, Merck’s preservative-free formulation of Cosopt, indicated for the reduction of elevated intraocular pressure in appropriate patients with open-angle glaucoma or ocular hypertension; and Zioptan (tafluprost ophthalmic solution), a preservative-free prostaglandin analogue ophthalmic solution. One must carefully consider any such statement and should understand that many factors could cause actual results to differ materially from the Company’s forward-looking statements. The Company anticipates that sales in the United States, which were approximately $450 million in 2011, and in these European markets will decline significantly after these patent expiries. F. van Gusteren et al, Computer simulation of molecular dynamics: Methodology, applications and perspectives in chemistry, Angew. There are clearly many determinants of sensitivity and resistance to antimitotic drugs, both at the level of the cells themselves and at the level of the pharmacological accessibility of the drugs to the tumour cells. MK-3814, preladenant, is a selective adenosine 2a receptor antagonist in Phase III development for treatment of Parkinson’s disease. Many of the matters disclosed in the 2004 Jordan et al. Come here! The Company has experienced difficulties and delays in manufacturing of certain of its products. As is also disclosed in the Tuszynski paper, This could be due to changes in the electrostatics of tubulin, which although significantly screened by counter-ions does affect microtubule assembly by influencing dimer-dimer interactions over relatively short distances (approximately 5 nm) as well as the kinetics of assembly. Merck & Co, Inc. in accordance with the supply of the drug under instrument PB 122 of 2008 (Arrangements - Botulinum Toxin Program) made under Section 100 (1) (b) The problems that high molecular weight compounds have with poor water solubility are discussed in U. S. Pat. No. 6,541,509, In the method of the present invention, paclitaxel is administered to a subject in combination with discodermolide, such that a synergistic antineoplastic effect is produced. The rule of 5 was set forth by Christopher A. The Company cannot determine whether these proposals will be enacted into law or what, if any, changes may be made to such proposals prior to their being enacted into law. We performed these calculations on the model structures, typically using analysis tools within the Gromacs (Lindahl et al, 2001) molecular dynamics package (version 3.1.4).. Anti diabetes drug Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. Anti diabetes drug Blogs, Comments and Archive News The Modeller database is also referred to in the patent literature. The fact that tubulin isotypes differ markedly in the C-termini suggests that specific sequences may mediate the functional roles of the isotypes. It is important to emphasize that microtubues are not simple equilibrium polymers. International publication WO02/36603A2, the entire disclosure of which is hereby incorporated by reference into this specification, discloses nucleic acid molecules comprising a nucleotide sequence encoding a tubulin molecule. The Company’s research and development model is designed to increase productivity and improve the probability of success by prioritizing the Company’s research and development resources on disease areas of unmet medical needs, scientific opportunity and commercial opportunity. This Merger Restructuring Program is intended to optimize the cost structure of the combined company. Biol. Cell, 10: 947-949, 1999), and by J. Ao adquirir este cheque experiência, pode utilizá-lo na experiência sugerida ou em qualquer outra que esteja disponível no nosso site. The C-termini are the major sites of binding of the MAPs to tubulin. This fractional value is determined by expressing the IC50 of a drug acting in combination, as a function of the IC50 of the drug acting alone. Human health vaccines are sold primarily to physicians, wholesalers, physician distributors and government entities. The Tuszynski paper also discloses that In addition, we have been able to generate plausible conformations for the C-terminal regions. Além disso, o processo aumenta a oxigenação local, melhora a circulação sanguínea na região, promove a drenagem de líquidos e toxinas retidos no organismo. In one embodiment, the magnetic anti-mitotic drugs of this invention bind directly to soluble tubulin. Each manufacturer’s portion of the total annual fee is based on the manufacturer’s proportion of the total includable sales in the prior year. Indeed some of the specific agents have uses against more than one class of organism. It is also noteworthy that 2-methoxyestradiol is a natural mammalian metabolite of estradiol and may play a cell growth regulatory role especially prominent during pregnancy. Chem. Lab. Med, 40: 918-925, 2002). These short-range interactions have recently been studied by Sept et al.
Taxol suppresses dynamics of individual microtubules in living human tumor cells, Mol. During 2011, the FDA approved an expanded age indication for Zostavax [Zoster Vaccine Live], a vaccine to help prevent shingles (herpes zoster), to include adults ages 50 to 59. 44334.85: 47012.18: TBA1_SCHPO −2.56E+000 −1.26E Dolastatin-10 (Pettit et al, J. Am. Chem. Soc, 1987; Pettit et al, Anti-Cancer Drug Des, 1998), and Rev. Cytol. 178:207-275, 1998). This clinically-promising class of therapeutics, called Tubulin Binding Agents, exhibit potent tumor cell cytotoxicity by efficiently inhibiting the polymerization of αβ-tubulin heterodimers into the microtubule structures that are required for facilitation of mitosis or cell division (Hamel, Medicinal Research Reviews, 1996).. P. Erickson, FtsZ, a tubulin homologue, in prokaryote cell division, Trends Cell Biol, 7:362-367, 1997. Additionally, many countries in the European Union (the “EU”) have undertaken austerity measures aimed at reducing costs in health care and have implemented pricing actions that negatively impacted sales in 2011. Med. Chem Anti-Cancer. Upon formulation of this hypothesis concerning ER molecular templates, our initial design and synthesis efforts centered on benzo[b]thiophene ligands modeled after raloxifene, the selective estrogen receptor modulator (SERM) developed by Eli Lilly and Co.. Rossi et al. The markets in which the Company conducts its business and the pharmaceutical industry are highly competitive and highly regulated. Click here. In addition, the Merck Patient Assistance Program provides medicines and adult vaccines for free to people who do not have prescription drug or health insurance coverage and who, without the Company’s assistance, cannot afford their Merck medicine and vaccines. Low solubility anti-cancer agents are difficult to solubulize and supply at therapeutically useful levels. Conservation of amino acid residues is approximately 40% between the alpha.- and β-tubulin families, and 85-90% within each of the alpha.- and β-tubulin families. Antimicrob. Chemother, 11(5):427-433 (1983). Sales for 2009 only include revenue from legacy Schering-Plough and MSP Partnership products for the post-Merger period through December 31, 2009. The Company’s products, including products in development, can not be marketed unless the Company obtains and maintains regulatory approval. Combination Therapy for Patients with six classes of oral antidiabetic drugs Marchetti P. β-cell function and anti-diabetic pharmacotherapy. Diabetes As previously disclosed, the U. S. Ser. No. 60/516,134, filed on Oct. As further used herein, the term paclitaxel biological activity refers to paclitaxel activity which interferes with cellular mitosis by affecting microtubule formation and/or action, thereby producing antimitotic and antineoplastic effects.
No comments:
Post a Comment